阿斯利康GLP-1减肥药二期数据将公布

DoNews
Jan 14

2026年1月14日,阿斯利康首席财务官表示,公司GLP-1减肥药的第二阶段临床试验数据预计将在今年内发布。该药物目前正处于研发关键阶段,旨在拓展公司在代谢疾病领域的布局。此次数据公布时间未具体说明,但预计将对后续研发及市场预期产生重要影响。阿斯利康正持续推进相关临床研究,以验证其安全性和有效性。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10